A very successful debate was held at the Society for Biomaterials meeting in April on the topic Clinical studies are the only true predictor of safety and efficacy for all new medical technologies.
At the beginning, the vote was very slightly in favor of the “for” side. After arguments both for and against, the “against” side took home the victory by a slight margin.
Thank you very much to the participants and those who attended!